Unknown

Dataset Information

0

Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis.


ABSTRACT: In contrast with the early view of metalloproteases as simple extracellular matrix-degrading entities, recent findings show that they are highly specific modulators of different signaling pathways involved, positively or negatively, in tumor development. Thus, before considering a given metalloprotease a therapeutic target, it seems advisable to characterize its function by identifying its repertoire of substrates. Here, we present a proteomic approach to identify ADAM17 substrates by difference gel electrophoresis. We found that the shedding of the extracellular domain of the transferrin receptor and those of two cell-cell adhesion molecules, activated leukocyte cell adhesion molecule (ALCAM) and desmoglein 2 (Dsg-2), is increased in cells overexpressing ADAM17. Genetic evidence shows that while ADAM17 is responsible for the shedding of ALCAM, both ADAM17 and ADAM10 can act on Dsg-2. Activation of the epidermal growth factor receptor leads to the upregulation of the shedding of Dsg-2 and to the concomitant upregulation of ADAM17, but not ADAM10, supporting the ability of overexpressed ADAM17 to shed Dsg-2. These results unveil a role of ADAM10 and ADAM17 in the shedding of cell-cell adhesion molecules. Since loss of cell adhesion is an early event in tumor development, these results suggest that ADAM17 is a useful target in anticancer therapy.

SUBMITTER: Bech-Serra JJ 

PROVIDER: S-EPMC1489169 | biostudies-literature | 2006 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis.

Bech-Serra Joan J JJ   Santiago-Josefat Belén B   Esselens Cary C   Saftig Paul P   Baselga José J   Arribas Joaquín J   Canals Francesc F  

Molecular and cellular biology 20060701 13


In contrast with the early view of metalloproteases as simple extracellular matrix-degrading entities, recent findings show that they are highly specific modulators of different signaling pathways involved, positively or negatively, in tumor development. Thus, before considering a given metalloprotease a therapeutic target, it seems advisable to characterize its function by identifying its repertoire of substrates. Here, we present a proteomic approach to identify ADAM17 substrates by difference  ...[more]

Similar Datasets

| S-EPMC2696121 | biostudies-literature
| S-EPMC4412975 | biostudies-literature
| S-EPMC2822761 | biostudies-literature
| S-EPMC3277759 | biostudies-literature
| S-EPMC9279611 | biostudies-literature
| S-EPMC4009800 | biostudies-literature
| S-EPMC8305989 | biostudies-literature
| S-EPMC4865905 | biostudies-literature
| S-EPMC3167202 | biostudies-literature
| S-EPMC3822429 | biostudies-literature